Open AccessTwo Cases of SARS-CoV-2 Infection in Pediatric Oncohematologic Patients in Spain
Author(s) -
Iñigo Pérez-Heras,
Verónica Fernandez-Escobar,
María Del Pozo-Carlavilla,
Raquel Díaz-Merchán,
María Eli Valerio-Alonso,
Nerea DomínguezPinilla
Publication year - 2020
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002841
Subject(s) - medicine , lopinavir , pediatric cancer , disease , ritonavir , pediatrics , covid-19 , respiratory system , respiratory infection , diarrhea , coronavirus , cancer , intensive care medicine , immunology , virus , infectious disease (medical specialty) , viral load , antiretroviral therapy
Since December 2019, severe acute respiratory syndrome coronavirus 2 infection has spread worldwide. We all are concerned about immunocompromised children, especially hematologic and oncologic pediatric patients. We want to share our experience with 2 pediatric cancer patients with severe acute respiratory syndrome coronavirus 2 infection. Both presented mild disease and good outcome. No respiratory symptoms were identified, but both developed diarrhea, one probably secondary to lopinavir/ritonavir. Pediatric cancer patients may have milder disease than adults, but larger studies are needed to make conclusions.